-
NU7441: DNA-PK Inhibition in HIV Latency Assays
2026-09-11
NU7441 (KU-57788) provides a precise way to interrogate DNA-PK-dependent repair in HIV latency and telomere vulnerability studies. This article translates foundational findings into assay design decisions, controls, and interpretation strategies for DNA repair research and oncology research.
-
5-EdU Workflows for CNS Repair Research
2026-09-11
5-Ethynyl-2'-deoxyuridine (5-EdU) provides a rapid, antibody-free way to map S phase DNA synthesis in injured neural tissue and cultured glia. This guide translates astrocyte–microglia repair biology into practical pulse-labeling, imaging, flow cytometry, and troubleshooting workflows.
-
Endothelial SGK1 Drives Salt-Related Vascular Stiffening
2026-09-10
Zhang et al. show that endothelial SGK1 links mineralocorticoid and high-salt signaling to endothelial and arterial stiffening through sodium-channel activity and actin remodeling. Genetic deletion and pharmacological inhibition establish a mechanistic framework for studying SGK1 in salt-sensitive vascular disease while also defining important limits for translating cell-culture findings.
-
Cy5-UTP for RNA Labeling and LNP Tracking
2026-09-10
Cy5-UTP enables direct far-red visualization of T7-transcribed RNA for FISH, probe development, and delivery studies. This practical guide connects controlled RNA labeling with charge- and cell-state-aware LNP experiments while separating particle association from functional delivery.
-
Cy3 TSA Fluorescence System Kit for Cell Mapping
2026-09-09
The Cy3 TSA Fluorescence System Kit can turn difficult single-cell receptor-expression questions into tractable fluorescence assays. This article connects tyramide chemistry with the TRIM66 olfactory-receptor study to explain how assay architecture, spatial localization, and signal amplification should guide experimental decisions.
-
BPN-19186 and the Liver–Bone Redox Axis
2026-09-09
A translational framework for evaluating BPN-19186 in sEH–Nrf2 research, connecting metabolite biology, osteoclastogenesis, assay design, and evidence-based compound selection.
-
Tubastatin A Protects the Post-Resuscitation Heart
2026-09-08
A 2025 Resuscitation Plus study used a porcine cardiac arrest and resuscitation model to examine how Tubastatin A affects myocardial injury after global ischemia–reperfusion. The treatment was associated with improved cardiac function, lower injury biomarkers, and reduced molecular signatures of GSDME-mediated pyroptosis and MLKL-mediated necroptosis, although the mechanism remains provisional.
-
Coumestrol-Induced Ferroptosis in RA Synoviocytes
2026-09-08
A 2026 study identifies a mechanistic link between Coumestrol, mitochondrial PMAIP1 stabilization, and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. The findings connect reduced synoviocyte proliferation and inflammatory cytokine production with inhibition of TRIM3-mediated protein degradation, while also defining important limits for translation beyond the cellular model.
-
Cytochalasin D for Actin-Dependent Uptake Assays
2026-09-07
Cytochalasin D is an actin polymerization inhibitor for testing whether cytoskeletal remodeling drives nanoparticle internalization in corneal epithelial models. This workflow pairs controlled cytoskeletal perturbation with particle-size, surface-chemistry, viability, and localization readouts to distinguish true uptake effects from nonspecific cellular injury.
-
AG-490 Workflow for JAK2/STAT6 Research
2026-09-05
AG-490, also called Tyrphostin B42, offers a practical pharmacological probe for testing JAK2/STAT6 signaling in exosome-driven macrophage polarization. This workflow combines pathway-focused dosing, EGFR-aware controls, and orthogonal readouts for reproducible cancer research.
-
DOT1L–Lenalidomide Synergy in Myeloma
2026-09-05
A 2025 Cancer Letters study identifies DOT1L as a preferential epigenetic dependency in multiple myeloma and links its inhibition to DNA-sensing, type I interferon, and HLA class II responses. The work further shows that DOT1L inhibition can potentiate lenalidomide activity by strengthening innate immune gene expression and suppressing IRF4–MYC signaling.
-
Neurotensin for GPCR Trafficking Studies
2026-09-04
Neurotensin provides a practical way to connect NTR1 activation with receptor recycling and miR-133α responses in gastrointestinal models. This workflow combines time-resolved cell assays, disciplined peptide handling, and fluorescence-data quality control for more reproducible mechanism studies.
-
Affinity-Purified Goat Anti-Rabbit IgG (H+L) Guide
2026-09-04
Build sensitive Western blot, ELISA, IHC, and immunocytochemistry workflows with an HRP-labeled reagent designed for rabbit primary antibodies. This practical guide connects assay optimization to recent hepatic fibrosis research while separating evidence-based findings from recommended starting conditions.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-09-03
Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange-emitting NHS ester for labeling primary amino groups in proteins, peptides, and nucleic acids. It is appropriate when DMSO or DMF can be tolerated, but it is not suitable for water-only labeling workflows or targets that are destabilized by organic co-solvents.
-
Citron OGD2 and Iron-ROS Defense Against Citrus Canker
2026-09-03
The reference study identifies CmOGD2 as a central regulator of citron resistance to Xanthomonas citri by connecting iron uptake, reactive oxygen species accumulation, and ferroptosis-like cell death. It also reveals a regulatory circuit involving CmENO2, CmZAT10.1, and the pathogen effector pthA4, providing a mechanistic framework for studying nutrient-dependent plant immunity.